Improving the embryonic stem cell test (EST) by standardizing protocols for development into nerve and cartilage tissue

被引：0
|
作者：
Buesen, R [1 ]
Seiler, A [1 ]
Visan, A [1 ]
Slavik, B [1 ]
Genschow, E [1 ]
Spielmann, H [1 ]
机构：
[1] Fed Inst Risk Assessment BfR, Natl German Ctr Documentat & Evaluat Alternat, D-12277 Berlin, Germany
来源：
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY | 2003年 / 367卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
632
引用
下载
收藏
页码：R161 / R161
页数：1
相关论文
共 50 条
  • [1] Improving the embryonic stem cell test (EST) by establishing molecular endpoints of tissue specific development
    Büsen, R
    Seiler, A
    Pohl, I
    Visan, A
    Genschow, E
    Speilmann, H
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2002, 365 : R132 - R132
  • [2] Trends in improving the embryonic stem cell test (EST): an overview
    Buesen, R
    Visan, A
    Genschow, E
    Slawik, B
    Spielmann, H
    Seiler, A
    ALTEX-ALTERNATIVEN ZU TIEREXPERIMENTEN, 2004, 21 (01): : 15 - 22
  • [3] Improving the embryonic stem cell test (EST) by establishing molecular endpoints of tissue specific development using murine embryonic stem cells (D3 cells)
    Seiler, A
    Visan, A
    Pohl, I
    Genschow, E
    Buesen, R
    Spielmann, H
    ALTEX-ALTERNATIVEN ZU TIEREXPERIMENTEN, 2002, 19 : 55 - 63
  • [4] Improving the embryonic stem cell test (EST) by establishing molecular endpoints: A prevalidation study
    Buesen, R
    Visan, A
    Slawik, B
    Schlechter, K
    Genschow, E
    Spielmann, H
    Seiler, A
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2004, 369 : R112 - R112
  • [5] Improving the embryonic stem cell test (EST) by establishing molecular endpoints: A prevalidation study
    Buesen, R
    Visan, A
    Slawik, B
    Schlechter, K
    Genschow, E
    Spielmann, H
    Seiler, A
    TOXICOLOGY AND APPLIED PHARMACOLOGY, 2004, 197 (03) : 365 - 365
  • [6] Innovative approaches in the embryonic stem cell test (EST)
    Theunissen, Peter T.
    Piersma, Aldert H.
    FRONTIERS IN BIOSCIENCE-LANDMARK, 2012, 17 : 1965 - 1975
  • [7] Prevalidation of the embryonic stem cell test (EST) -: A new in vitro embryotoxicity test
    Scholz, G
    Genschow, E
    Pohl, I
    Bremer, S
    Paparella, M
    Raabe, H
    Southee, J
    Spielmann, H
    TOXICOLOGY IN VITRO, 1999, 13 (4-5) : 675 - 681
  • [8] Molecular and cellular endpoints of embryotoxicity in the embryonic stem cell test (EST)
    Clemann, Nicole
    Festag, Matthias
    TOXICOLOGY LETTERS, 2009, 189 : S53 - S53
  • [9] Optimization of embryonic stem cell test (EST) and opportunities to improve it's predictivity
    Birk, B.
    Flick, B.
    Ramirez, T.
    Jiang, X.
    Dammann, M.
    Huener, H. A.
    Stein, N.
    van Ravenzwaay, B.
    Landsiedel, R.
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2017, 390 : S86 - S86
  • [10] Embryotoxic potential of the nanomaterials and biomaterials by improvement of embryonic Stem Cell Test (EST)
    Imai, Koichi
    Nano Biomedicine, 2015, 7 (01) : 28 - 39
12345